|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-8-18
|
|
pubmed:abstractText |
To quantify adverse events (AEs) associated with the use of metformin (MET), sulphonylureas (SUs) and thiazolidinediones (TZDs) in a usual care setting, and to assess the relationship of AEs to treatment patterns and glycaemic response in patients with type 2 diabetes. RESEARCH DESIGN and
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1463-1326
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
638-45
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17645555-Administration, Oral,
pubmed-meshheading:17645555-Adolescent,
pubmed-meshheading:17645555-Adult,
pubmed-meshheading:17645555-Diabetes Mellitus, Type 2,
pubmed-meshheading:17645555-Female,
pubmed-meshheading:17645555-Hemoglobin A, Glycosylated,
pubmed-meshheading:17645555-Humans,
pubmed-meshheading:17645555-Hypoglycemic Agents,
pubmed-meshheading:17645555-Male,
pubmed-meshheading:17645555-Metformin,
pubmed-meshheading:17645555-Middle Aged,
pubmed-meshheading:17645555-Sulfonylurea Compounds,
pubmed-meshheading:17645555-Thiazolidinediones,
pubmed-meshheading:17645555-Treatment Outcome,
pubmed-meshheading:17645555-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Association between oral antidiabetic use, adverse events and outcomes in patients with type 2 diabetes.
|
|
pubmed:affiliation |
Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT 84108, USA. carl.asche@pharm.utah.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
